您当前的位置:
首页 >
文章列表页 >
暂无标题
更新时间:2022-06-21
    • 暂无标题

    • China Pharmacy   Vol. 32, Issue 16, (2021)
    • Published:2021,

    扫 描 看 全 文

  • [J]. China Pharmacy 32(16).(2021) DOI:

  •  
  •  

0

Views

8

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Research progress of traditional Chinese medicine in regulating Nrf2/HO-1 signaling pathway to interfere with myocardial ischemia-reperfusion injury
Research progress of the regulation effect of traditional Chinese medicine monomer of flavonoids on the pulmonary fibrosis signaling pathway
Research progress of stimulus-responsive transdermal drug delivery systems
Research progress of active ingredients of traditional Chinese medicine in the intervention of diabetic nephropathy by regulating mTOR signaling pathway
Research progress on signal pathways related to prevention and treatment of hypertension target organ damage by traditional Chinese medicine

Related Author

JIA Suxia
XU Xiaomin
YANG Huicong
LIU Shumin
MENG Jianhua
LIU Rui
PAN Ling
LUO Zhenzhen

Related Institution

Institute of Traditional Chinese Medicine,Heilongjiang University of Chinese Medicine
Graduate School, Guangxi University of Chinese Medicine
Dept. of Pulmonary and Critical Care Medicine,Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine
College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Peking Union Medical College & Institute of Radiation Medicine, Chinese Academy of Medical Sciences
0